| Bryan Waxman, MD | |
|
2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015-1836 | |
| (847) 914-9096 | |
| Not Available |
| Full Name | Bryan Waxman |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 32 Years |
| Location | 2101 Waukegan Rd, Bannockburn, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356396311 | NPI | - | NPPES |
| 036-090271 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 036-090271 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspire Home Healthcare, Llc | Morton grove, IL | Home health agency |
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Illinois Bone And Joint Institute Llc | 6002814878 | 519 |
News Archive
When combined with a detailed medical history, it can identify the causes of allergy symptoms and provide the basis for avoidance, environmental control and immunotherapy.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Workplace experiences of minority resident physicians in training are described in a new study.
Omeros Corporation today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits.
Today's headlines include the latest developments regarding congressional action on the veterans' health care scandal as well as reports about the latest Medicaid enrollment figures in the context of the health law.
› Verified 4 days ago
| Entity Name | Illinois Bone And Joint Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205922432 PECOS PAC ID: 6002814878 Enrollment ID: O20061110000331 |
News Archive
When combined with a detailed medical history, it can identify the causes of allergy symptoms and provide the basis for avoidance, environmental control and immunotherapy.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Workplace experiences of minority resident physicians in training are described in a new study.
Omeros Corporation today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits.
Today's headlines include the latest developments regarding congressional action on the veterans' health care scandal as well as reports about the latest Medicaid enrollment figures in the context of the health law.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryan Waxman, MD 900 Rand Rd Ste 300, Atn: Raquel Leon, Des Plaines, IL 60016-2359 Ph: (847) 324-3976 | Bryan Waxman, MD 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015-1836 Ph: (847) 914-9096 |
News Archive
When combined with a detailed medical history, it can identify the causes of allergy symptoms and provide the basis for avoidance, environmental control and immunotherapy.
Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Workplace experiences of minority resident physicians in training are described in a new study.
Omeros Corporation today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits.
Today's headlines include the latest developments regarding congressional action on the veterans' health care scandal as well as reports about the latest Medicaid enrollment figures in the context of the health law.
› Verified 4 days ago
Jonathan S Erulkar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-914-9096 | |
Charles Lettvin, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-914-9096 | |
Arthur Kroft, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-914-9096 | |
Arnold Cohn, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-914-9096 | |
Dr. Sean Sutphen, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Waukegan Rd Ste 110, Bannockburn, IL 60015 Phone: 847-914-9096 Fax: 847-914-9009 | |
Richard Sherman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Waukegan Rd, Suite 110, Bannockburn, IL 60015 Phone: 847-914-9096 |